Design of adjuvant chemotherapy based on target cell determinants of drug action: possibilities and limitations.
D000818:Animals; D000970:Antineoplastic Agents / Q000378:metabolism / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D003561:Cytarabine / Q000378:metabolism / Q000494:pharmacology; D004341:Drug Evaluation; D006801:Humans; D007942:Leukemia, Experimental / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000378:metabolism; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D012107:Research Design
D000970:Antineoplastic Agents; D003561:Cytarabine